glp 1 cardiovascular disease and mortality outcomes with GLP-1 receptor agonists vs other glucose-lowering drugs in individuals with NAFLD and type 2 diabetes: a large population-based matched cohort study | Diabetologia Cardiovascular Protective Properties of GLP-1
Description
When severe symptoms dont respond to diet, medication may be an option
Enhancing Every Step of the Weight Loss Journey While achieving your weight loss goals is important, how you get there matters just as much
Association of sleep apnea and type II diabetes: a population-based study
(2023, August 3)
